CO2-ZSE can effectively treat migraine, increase the expression of 5-HT, decrease the expression of NO, CGRP, and ET-1 to regulate vasomotor and inhibit the expression of NF-κBp65, IκBα, and IL-1β to alleviate neurogenic inflammation. The gene discussed is EDN1; the disease is migraine disorder.